主页 > 医学讨论 >
【bio-news】哪些乳腺癌患者对抗雌激素治疗有效
A discovery by Australian scientists could help clinicians decide which women with breast cancer will make good candidates for anti-oestrogen therapies, such as tamoxifen, and which will not.
Over 12,000 Australian women are diagnosed with breast cancer each year, roughly 70% of which will have cancers treatable with tamoxifen. Unfortunately, 30% or more of these women may not respond well to such anti-hormone therapy long-term.
Work done by a research team headed by Associate Professor Liz Musgrove and Professor Rob Sutherland of Sydney’s Garvan Institute of Medical Research has correlated expression of certain functionally-related oestrogen-regulated genes with predictable clinical outcomes. This expanded knowledge about oestrogen action and endocrine resistance should allow clinicians to make better, more informed, choices in the future.
“What we call ‘breast cancer’ is actually many different kinds of cancer, some of which appear to be driven by the female hormone oestrogen,” said Professor Musgrove. “We found roughly 800 genes that are regulated by oestrogen, each with a different function in the cell, so you can imagine how complicated the picture can become when you are trying to correlate the effects of all these genes with multiple cancers.”
In fact, the scale of such calculations, and complex biochemistry behind them, requires the help of large relational databases, powerful software and the agile minds of bioinformatics specialists to crunch and analyse data.
Out of the undifferentiated pool of oestrogen-regulated genes, the team has identified four groupings of genes, with each group relating to one aspect of breast cancer cell behaviour: cell cycle (proliferation), cell growth (actual size of the cell), cell death and gene transcription.
Professor Musgrove stresses the clinical relevance of the findings. “In collaboration with colleagues at the Peter MacCallum Cancer Centre in Melbourne, we took these 4 groups of genes and asked whether they were related to outcome in a sample of 246 women who’d been treated with tamoxifen. We were able to directly relate 3 out of the 4 groups, all but gene transcription, to whether a woman had done better or worse when treated with tamoxifen.”
“We then went on to ask whether we were looking at three different ways of identifying the same women, or whether the three groups of genes identified distinct groups of women, with different breast cancers. It appears as if they identify distinct groups of women with different cancers.”
“Developing pure lists of genes that are involved in single processes gives us a good conceptual and experimental framework. In time we hope to understand how these groups of genes interact, and exactly how they affect disease or health.”
http://www.sciencedaily.com/releases/2008/09/080908101645.htm 本人已认领该文编译，48小时后若未提交译文，请其他战友自由认领。 Calculating How Breast Cancers Will Respond To Tamoxifen
A discovery by Australian scientists could help clinicians decide which women with breast cancer will make good candidates for anti-oestrogen therapies, such as tamoxifen, and which will not.
澳大利亚科学家的一个发现可能帮助临床医生决定哪些乳腺癌妇女适宜接受抗雌激素治疗，比如他莫西酚，而哪些不适宜接受该治疗。
Over 12,000 Australian women are diagnosed with breast cancer each year, roughly 70% of which will have cancers treatable with tamoxifen. Unfortunately, 30% or more of these women may not respond well to such anti-hormone therapy long-term.
每年有超过12000澳大利亚妇女被诊断为乳腺癌，大约70%将接受他莫西酚的治疗。不幸的是这些妇女中的30% 或更多对这些抗激素治疗长期效果并不好。
Work done by a research team headed by Associate Professor Liz Musgrove and Professor Rob Sutherland of Sydney’s Garvan Institute of Medical Research has correlated expression of certain functionally-related oestrogen-regulated genes with predictable clinical outcomes. This expanded knowledge about oestrogen action and endocrine resistance should allow clinicians to make better, more informed, choices in the future.
悉尼的Garvan 医学研究院的Liz Musgrove副教授和Rob Sutherland教授所领导的研究团队已完成的工作显示特定的功能相关的雌激素调节基因的表达与临床预后相关。这些扩大了我们关于雌激素作用和内分泌抵抗知识的认识，进而让临床医生将来做得更好，获得更多的信息和作出更恰当的选择。
“What we call ‘breast cancer’ is actually many different kinds of cancer, some of which appear to be driven by the female hormone oestrogen,” said Professor Musgrove. “We found roughly 800 genes that are regulated by oestrogen, each with a different function in the cell, so you can imagine how complicated the picture can become when you are trying to correlate the effects of all these genes with multiple cancers.”
阅读本文的人还阅读：
作者:admin@医学,生命科学 2010-11-14 05:11
医学,生命科学网